Delivery Order SPE2DB22D2206-SPE2DB25FJM08
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $10,623.60 to AmerisourceBergen Drug Corp for SAMSCA 15 mg tablets (10-count units) on August 15, 2025, with completion scheduled for September 8, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical vendor for...
- The Defense Logistics Agency awarded a $10,623.60 firm fixed-price delivery order to AmerisourceBergen Drug Corp for SAMSCA 15 mg tablets (10-count units) with an ultimate completion date of September 15, 2025. This non-set-aside competitive award was issued on August 22, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, was selected through...
- AmerisourceBergen Drug Corp was awarded a delivery order by the Defense Logistics Agency (DLA) on July 28, 2025, for the supply of Samsca 15 mg tablets (10-count packages) valued at $7,082.40 with a firm fixed price structure. The contract, which is not set-aside and was competitively awarded, requires completion by August 18, 2025, with performance to be executed from the company's corporate office location in Conshohocken, Pennsylvania. This delivery order falls under AmerisourceBergen Drug...
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract valued at $10,269.78 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. This contract is for the delivery of SAMSCA 15 MG TABLET 10S pharmaceutical products, with a performance period ending on March 27, 2024. Amerisourcebergen Drug Corp, a for-profit organization, has previously received numerous federal contract awards from DLA Troop Support Medical to supply pharmaceuticals,...
- This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA), a defense agency. The $10,623.60 firm fixed-price delivery order contract is for the supply of SAMSCA 15 MG TABLET 10S, a pharmaceutical product. The contract has an ultimate completion date of June 13, 2025 and was awarded on May 22, 2025. The award is not designated as a set-aside and represents an open competition....
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of the pharmaceutical distribution company Amerisourcebergen Corporation. The $20,539.62 contract is for the delivery of SAMSCA 15 MG TABLET 10S to a location in Conshohocken, Pennsylvania. The contract has a completion date of February 16, 2024 and was awarded on January 26, 2024. This delivery order is issued under a larger, single-award indefinite delivery...
- The Defense Logistics Agency awarded a delivery order valued at $7,348.68 to AmerisourceBergen Drug Corp for the supply of Samsca 30 mg tablets (10-count) under a firm fixed price contract. The award was issued on July 31, 2025, with an ultimate completion date of August 21, 2025. This competitively awarded, non-set-aside contract represents a child delivery order executed against AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), which is...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $44,080.92 firm fixed price delivery order is for the supply of SAMSCA 30 MG TABLET 10S, a pharmaceutical product. The contract has an ultimate completion date of December 30, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a for-profit pharmaceutical distribution company, for the supply of SAMSCA 15 MG TABLET 10S. The $10,269.78 delivery order is part of a larger indefinite delivery contract (IDC) with a potential value of $999,999,999.00 awarded to Amerisourcebergen Drug Corp as the sole prime contractor. This IDC serves as the primary vehicle for Amerisourcebergen to provide pharmaceutical products and...
- This is a federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) for the delivery of SAMSCA 15 MG TABLET 10S. The contract is a Firm Fixed Price Delivery Order valued at $10,261.68, with a period of performance through March 24, 2023. The contract was not designated as a set-aside. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 through...
- SPE2DB22D2206Indefinite Delivery Contract
- SPE2DB22D2206-SPE2DB25FJM08Delivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 18, 2025, for the supply of SAMSCA 15 mg tablets (10 count) with a ceiling value of $10,623.60. This firm fixed-price delivery order, which is not set-aside, is scheduled for completion by September 9, 2025, and will be performed at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. The award represents a continuation of the company's role as a critical pharmaceutical supplier to federal medical procurement needs. This delivery order is issued under AmerisourceBergen Drug Corp's substantial Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. This prime contract vehicle enables the company to supply a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally, including the Defense Health Agency and U.S. Coast Guard. AmerisourceBergen's federal contract portfolio demonstrates its capacity to fulfill competitive procurement requirements across diverse therapeutic domains, from specialty medications to generic drugs and medical devices, making it a key vendor for federal medical supply needs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $10.6k | 8/18/25 |